Testing Morbidities Index clinical trials

MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer

This study looks at whether advanced breast cancer that's HER2+ or 'triple negative' has spread to the brain, even if there are no symptoms. It uses special MRI scans and blood tests to find out and understand how patients feel about these tests.